Hip Replacement Market Size, Share, Growth, and Industry Analysis, By Types (Metal-on-Polyethylene (MoP), Metal-on-Metal (MoM), Ceramic-on-Polyethylene (CoP), Ceramic-on-Ceramic (CoC), Ceramic-on-Metal (CoM)), By Applications Covered (Primary THA, Partial Hip, Hip Resurfacing, Revision Hip Arthroplasty), Regional Insights and Forecast to 2033

Hip Replacement Market Size

The Hip replacement market was valued at USD 8,486.5 million in 2024 and is projected to reach USD 8,766.56 million in 2025, with further growth to USD 11,366.63 million by 2033, exhibiting a compound annual growth rate (CAGR) of 3.3% during the forecast period from 2025 to 2033.

The U.S. hip replacement market is the largest globally, driven by an aging population, increasing prevalence of hip osteoarthritis, and advancements in surgical techniques. The market is expected to maintain steady growth due to these factors.

The global hip replacement market was valued at approximately USD 6.3 billion in 2022 and is expected to expand significantly, reaching USD 10.38 billion by 2031. This growth reflects a compound annual growth rate (CAGR) of 5.7% during the forecast period. The increasing prevalence of hip osteoarthritis, especially among the aging population, is driving the demand for hip replacement surgeries. As the global population continues to age, the need for hip replacement procedures is expected to rise significantly, contributing to the market’s steady growth. This market is expected to grow at a steady rate, driven by a growing healthcare sector and advancements in surgical techniques. The demand for hip replacement surgeries is anticipated to increase by 7.2%, fueled by higher rates of hip joint disorders among individuals over 60 years. Additionally, technological innovations in implant materials and techniques are expected to drive an estimated 6.5% increase in market growth, enhancing surgical outcomes and recovery times. As the healthcare sector grows, the adoption of minimally invasive procedures is expected to boost the market by 5.4%, reflecting the shift towards more efficient and cost-effective treatment options.

Hip Replacement Market Trends

The global hip replacement implants market was valued at USD 5.2 billion in 2020 and is projected to grow at a rate of 5.8% annually, reaching USD 7 billion by 2030. A major trend in this market is the increasing adoption of advanced bearing surfaces, such as ceramic-on-ceramic (CoC) and ceramic-on-metal (CoM), which offer reduced wear rates and improve the longevity of implants. These materials have gained popularity as alternatives to metal-on-metal (MoM) implants, which have faced concerns regarding potential health risks, such as metal ion release. Additionally, the growing incidence of obesity, a major risk factor for hip osteoarthritis, is expected to continue driving the demand for hip replacement surgeries, especially in countries with rising obesity rates. The market is expected to witness a growth rate of approximately 6.2% due to the increasing demand for innovative implant materials.

Hip Replacement Market Dynamics

The hip replacement market is shaped by several key dynamics. One of the primary drivers is the aging global population, which increases the prevalence of hip joint diseases, leading to a higher demand for surgeries. Technological advancements in implant materials and surgical techniques have also significantly improved patient outcomes, making hip replacement surgeries more appealing to patients. Furthermore, the expansion of health insurance coverage and reimbursement policies has made these surgeries more accessible to a larger population. However, the market is restrained by complications associated with implants, such as wear and potential toxicity from metal implants, and the high costs of surgeries, which can limit accessibility for some patients. On the opportunity side, emerging markets, especially in developing countries, present significant growth potential, estimated at 7.2%, as healthcare infrastructure improves. The rise of minimally invasive surgical techniques, which offer quicker recovery times and lower healthcare costs, also provides an opportunity for market growth, with an expected growth rate of 5.9%. Addressing these challenges while capitalizing on emerging opportunities will be essential to sustain the market’s growth trajectory.

DRIVER

" Increasing Prevalence of Hip Osteoarthritis"

The primary driver of market growth is the rising incidence of hip osteoarthritis, particularly in the aging population. It is estimated that by 2050, 20% of adults over 60 will experience osteoarthritis, a condition that significantly contributes to hip joint degradation. This growing prevalence is fueling the demand for hip replacement surgeries. Additionally, lifestyle factors such as obesity, which affects around 40% of the global population, are further exacerbating the incidence of joint diseases, increasing the need for surgical intervention. Technological advancements in implant materials and surgical methods are also driving market expansion by offering improved outcomes and faster recovery times.

RESTRAINTS

" Concerns Over Implant Longevity and Safety"

One of the major restraints in the hip replacement market is the concern over the longevity and safety of implants. Studies show that nearly 10-15% of metal-on-metal (MoM) implants fail prematurely, leading to the need for revision surgeries. Complications, such as implant wear and metal ion release, which can lead to adverse health effects, are contributing to hesitancy among patients and healthcare providers. Furthermore, the high cost of implants and surgery is a significant barrier, particularly in developing countries, where access to healthcare and affordability remain key issues. This limits the growth potential of the market in some regions.

OPPORTUNITY

" Advancement in Minimally Invasive Techniques"

There is a significant opportunity in the growing adoption of minimally invasive hip replacement surgery. These techniques, which result in smaller incisions and quicker recovery times, are becoming increasingly popular among both patients and healthcare providers. With a focus on enhancing patient outcomes, minimally invasive procedures are expected to lead to a higher adoption rate in the coming years. Additionally, the development of custom-made implants, tailored specifically to an individual’s anatomy, is creating an opportunity for personalized solutions that could reduce complications and improve outcomes. The shift toward personalized medicine is expected to capture a larger portion of the market as patient demand for specialized solutions grows.

CHALLENGE

" High Costs and Post-Surgical Complications"

A key challenge facing the hip replacement market is the high cost of procedures and the associated risk of complications. The average cost of hip replacement surgery, including post-surgery care, can exceed USD 30,000 in developed markets, making it unaffordable for some patients. Furthermore, the risk of complications such as infections, blood clots, and implant failure remains a significant concern. Studies show that around 5-10% of patients experience complications that require additional surgeries. These factors contribute to a slower adoption rate of hip replacement surgeries in regions with limited healthcare access, especially in developing economies where cost is a major barrier to treatment.

Segmentation Analysis

The global hip replacement market is segmented based on implant type and application. The implant types include Metal-on-Polyethylene (MoP), Metal-on-Metal (MoM), Ceramic-on-Polyethylene (CoP), Ceramic-on-Ceramic (CoC), and Ceramic-on-Metal (CoM), each offering distinct benefits based on material durability and wear resistance. The application segments include Primary Total Hip Arthroplasty (THA), Partial Hip, Hip Resurfacing, and Revision Hip Arthroplasty. Each application has varying demand based on factors such as patient age, the severity of hip degeneration, and the need for revision surgeries. Understanding the segmentation helps in identifying the driving factors for growth within each segment, contributing to the overall market expansion.

By Type

• Metal-on-Polyethylene (MoP): Metal-on-Polyethylene (MoP) remains one of the most widely used materials for hip replacement implants due to its cost-effectiveness and durability. It accounts for approximately 40% of the global market share. The combination of metal femoral components and polyethylene acetabular components offers a reliable and long-lasting solution. MoP implants are considered ideal for older patients or those with lower activity levels due to their relatively low wear rates compared to older materials. MoP implants are expected to maintain a strong position in the market due to their affordability and the established track record for safety.

• Metal-on-Metal (MoM): Metal-on-Metal (MoM) hip implants have been favored for their durability and strength, particularly in younger, more active patients. However, concerns over the release of metal ions into the body, causing potential toxicity and adverse health effects, have resulted in a decrease in demand. MoM implants represented about 25% of the market share but are gradually being replaced by ceramic-based materials. Despite the risks, the market for MoM implants is expected to remain stable in specific regions where healthcare providers still use them due to their mechanical strength, especially for patients with higher activity levels.

• Ceramic-on-Polyethylene (CoP): Ceramic-on-Polyethylene (CoP) implants are known for their exceptional wear resistance and lower risk of wear debris compared to metal-based materials. CoP implants are especially suited for patients seeking longevity in their hip replacements, contributing to an expected 10% market growth. Ceramic femoral heads are combined with polyethylene acetabular liners to offer a durable and biocompatible option. This type is increasingly preferred due to its reduced wear rates, which result in fewer revision surgeries. CoP implants are gaining traction among patients in need of long-term solutions, especially for older populations, due to their combination of durability and reduced risk of complications.

• Ceramic-on-Ceramic (CoC): Ceramic-on-Ceramic (CoC) implants are the most advanced type of hip replacement, known for their excellent wear resistance and low risk of wear particles. CoC implants are considered ideal for younger and more active patients due to their superior durability and low friction properties. They account for around 15% of the market share. CoC implants are particularly attractive because of their ability to last longer, minimizing the need for revision surgeries. The market for CoC implants is expected to grow at a steady pace, as more patients seek out high-performance, long-lasting options for hip replacement surgery.

• Ceramic-on-Metal (CoM):Ceramic-on-Metal (CoM) implants combine the durability of ceramic with the strength of metal, making them suitable for patients with higher activity levels. CoM implants are gaining popularity due to their wear resistance, which leads to longer-lasting implants compared to traditional MoP and MoM implants. Ceramic heads are paired with metal acetabular components to create a strong, durable implant with reduced wear rates. This combination makes CoM implants an appealing option for patients under 60, representing a growing segment in the market. The CoM segment is expected to capture a larger market share due to the increasing demand for high-durability implants.

By Application

• Primary Total Hip Arthroplasty (THA): Primary Total Hip Arthroplasty (THA) accounts for the largest share of the hip replacement market. It involves the complete replacement of the hip joint and is typically recommended for patients with severe osteoarthritis or other degenerative joint diseases. THA procedures are particularly common among older adults, with an estimated 85% of hip replacement surgeries being primary THA. This segment is expected to experience a steady growth rate of around 5.5% due to the aging population and increasing healthcare access. 

• Partial Hip Replacement: Partial hip replacement is typically performed for patients with fractures or arthritis affecting only a portion of the hip joint. This procedure accounts for approximately 10-15% of the hip replacement market. Partial hip replacement surgeries are less invasive and require a shorter recovery time compared to total hip replacement. As the demand for less invasive procedures grows, partial hip replacement is expected to capture a larger share of the market. 

• Hip Resurfacing: Hip resurfacing is a bone-conserving alternative to total hip replacement, designed to offer a solution for younger patients with hip joint disease. It is expected to account for around 10% of the global hip replacement market. This procedure involves capping the femoral head with a metal covering instead of replacing the entire hip joint. Hip resurfacing is particularly appealing for active individuals because it preserves more bone structure, providing a better long-term outcome. Despite its advantages.

• Revision Hip Arthroplasty: Revision Hip Arthroplasty is a surgical procedure performed when a previously implanted hip replacement fails, typically due to wear, infection, or other complications. This segment is expected to account for 5-10% of the market but is growing steadily as the number of primary hip replacement surgeries increases and patients live longer. With advancements in surgical techniques and implant materials, revision surgeries are becoming more successful. The demand for revision surgeries is expected to rise in the coming years, particularly as the population ages, increasing the need for re-implantation and maintenance of hip replacements.

Regional Outlook

The hip replacement market is globally diverse, with significant growth observed across various regions due to differences in demographics, healthcare infrastructure, and patient demand. North America, Europe, Asia-Pacific, and the Middle East & Africa are the key regions shaping the market's trajectory. North America dominates the global market, driven by high healthcare standards, increased awareness of joint diseases, and advanced surgical techniques. Europe follows closely, driven by an aging population and improved healthcare accessibility. Asia-Pacific is witnessing rapid growth due to rising healthcare investments and expanding healthcare access, particularly in countries like China and India. 

North America

North America holds the largest share of the global hip replacement market, accounting for nearly 40% of the market. The region’s high adoption rate of advanced surgical procedures and implants contributes to its dominance. The United States is the primary driver of this market, with approximately 400,000 hip replacement surgeries performed annually. Factors such as a rapidly aging population and increasing obesity rates are contributing to the rising demand for hip replacements. 

Europe

Europe is a significant market for hip replacement surgeries, holding a substantial share due to its aging population and well-developed healthcare systems. The market in Europe is valued at around 30% of the global market. Countries such as Germany, the UK, France, and Italy have seen consistent demand for hip replacement procedures. The prevalence of hip osteoarthritis and other joint-related disorders is driving the demand for these surgeries. Additionally, healthcare advancements and high-quality surgical procedures contribute to the market's growth.

Asia-Pacific

The Asia-Pacific region is experiencing rapid growth in the hip replacement market, driven by an increasing aging population, healthcare improvements, and rising economic growth. The region accounts for approximately 20% of the global hip replacement market, with countries like China, India, and Japan seeing the most significant demand. In China alone, the number of hip replacement surgeries has been increasing, with nearly 200,000 procedures performed annually. The rise in healthcare spending, coupled with growing awareness of joint health, is contributing to the market expansion. 

Middle East & Africa

The Middle East & Africa (MEA) region is emerging as an important market for hip replacement procedures, driven by increasing healthcare investments and improving infrastructure in countries like the UAE, Saudi Arabia, and South Africa. The market share of the MEA region is estimated at 5-7%, with growth observed in both private and public healthcare sectors. The aging population and increasing prevalence of joint diseases such as osteoarthritis in this region are fueling demand. In particular, the UAE and Saudi Arabia have been focusing on healthcare modernization and attracting medical tourism, contributing to the growth of hip replacement surgeries in these areas.

Key Players in the Hip Replacement Market

• Zimmer Biomet
• Johnson & Johnson
• Stryker
• Smith & Nephew
• B. Braun
• Medacta
• DJO Global
• Corin Group
• AK Medical
• Exactech
• Kyocera

Top companies with the highest market share 

• Zimmer Biomet – holds approximately 25% of the global market share.
• Johnson & Johnson – holds around 20% of the global market share.

Investment Analysis and Opportunities

The hip replacement market presents significant investment opportunities due to the rising demand for joint replacement procedures. Key opportunities lie in the expansion of emerging markets, where access to healthcare is improving and the aging population is rapidly increasing. The Asia-Pacific region, in particular, is attracting considerable investments, with countries such as China and India seeing a surge in healthcare infrastructure development. With over 200,000 hip replacement surgeries performed annually in China, the demand for high-quality implants and advanced surgical techniques is expected to increase substantially. Additionally, the growing prevalence of obesity and related joint diseases provides investors with opportunities to target specific markets such as ceramic-on-ceramic and ceramic-on-metal implants, which are becoming increasingly popular for younger, more active patients.

New Product Development

The hip replacement market is witnessing a wave of new product developments aimed at improving patient outcomes, reducing recovery times, and enhancing the longevity of implants. One key area of innovation is the development of advanced bearing surfaces. Companies are increasingly focusing on ceramic-on-ceramic (CoC) and ceramic-on-metal (CoM) implants, which offer improved wear resistance and lower friction, making them ideal for active and younger patients. These materials help to extend the lifespan of implants and reduce the likelihood of revision surgeries. Companies such as Zimmer Biomet and Stryker are investing heavily in research and development to refine their implant designs and improve the overall performance of their products. Additionally, the rise of custom-made implants tailored to individual patient anatomies is becoming a focal point, as these solutions offer better functionality and fit, reducing the risk of complications.

Recent Developments by Manufacturers 

• Zimmer Biomet launched the Persona Revision Knee System in early 2024, expanding its portfolio of joint replacement solutions. This system features innovative instrumentation designed for improved accuracy and ease of use during revision surgeries.
• Stryker introduced the Mako SmartRobotics system in 2023 for hip replacement surgeries, enabling greater precision in joint alignment, which leads to better patient outcomes and faster recovery times.
• Smith & Nephew unveiled its POLARSTEM hip stem system in late 2023, designed to enhance fixation and stability for younger, active patients. This new system is gaining recognition for its high durability.
• Johnson & Johnson launched the DePuy Synthes VELYS Hip System in 2023, offering surgeons an innovative robotic-assisted solution to improve precision in hip replacement surgeries, reducing recovery time for patients.
• Medacta expanded its product offerings by introducing a new line of MyKnee and MyHip systems in 2024, offering personalized implants with advanced materials to provide a better fit for individual patients, improving both safety and outcomes.

Report Coverage 

The report on the hip replacement market provides a comprehensive analysis of key market segments, including the types of implants—Metal-on-Polyethylene (MoP), Metal-on-Metal (MoM), Ceramic-on-Polyethylene (CoP), Ceramic-on-Ceramic (CoC), and Ceramic-on-Metal (CoM). It also includes insights into the various applications, such as Primary Total Hip Arthroplasty (THA), Partial Hip, Hip Resurfacing, and Revision Hip Arthroplasty. The report delves into market size, growth projections, and key trends shaping the industry, including technological advancements in implant materials, minimally invasive surgical techniques, and the growing prevalence of hip osteoarthritis. It also highlights the significant regional variations in the market, focusing on North America, Europe, Asia-Pacific, and the Middle East & Africa. Detailed competitor analysis, including key players like Zimmer Biomet, Stryker, and Johnson & Johnson, is also covered.